Browse > Article
http://dx.doi.org/10.5223/pghn.2019.22.6.545

Lactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants  

Kaban, Risma K. (Department of Pediatric Health, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital)
Wardhana, Wardhana (Department of Pediatric Health, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital)
Hegar, Badriul (Department of Pediatric Health, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital)
Rohsiswatmo, Rinawati (Department of Pediatric Health, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital)
Handryastuti, Setyo (Department of Pediatric Health, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital)
Amelia, Novie (Department of Pediatric Health, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital)
Muktiarti, Dina (Department of Pediatric Health, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital)
Indrio, Flavia (Department of Paediatrics, University of Bari)
Vandenplas, Yvan (KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel)
Publication Information
Pediatric Gastroenterology, Hepatology & Nutrition / v.22, no.6, 2019 , pp. 545-553 More about this Journal
Abstract
Purpose: Feeding tolerance is extremely important in preterm infants. This study aimed to evaluate whether preterm infants receiving Lactobacillus reuteri DSM 17938 would develop fewer symptoms of feeding intolerance. Secondary outcomes were duration of parenteral nutrition, time to reach full feeding, length of hospital stay, sepsis, necrotizing enterocolitis (NEC), diarrhea, and mortality. Methods: This double-blind randomized controlled trial of L. reuteri DSM 17938 versus placebo included 94 neonates with a gestational age of 28-34 weeks and birth weight of 1,000-1,800 g. Results: Feeding intolerance (vomiting and/or distension) was less common in the probiotic group than in the placebo group (8.5% vs. 25.5%; relative risk, 0.33; 95% confidence interval, 0.12-0.96; p=0.03). No significant intergroup differences were found in proven sepsis, time to reach full feeding, length of hospital stay, or diarrhea. The prevalence of NEC (stages 2 and 3) was 6.4% in the placebo group vs. 0% in the probiotic group (relative risk, 1.07; 95% confidence interval, 0.99-1.15; p=0.24). Mortality rates were 2.1% in the probiotic group and 8.5% in the placebo group, p=0.36). Conclusion: The administration of L. reuteri DSM 17938 to preterm infants was safe and significantly reduced feeding intolerance. No significant differences were found in any other secondary outcomes.
Keywords
Lactobacillus reuteri; Preterm; Feeding intolerance;
Citations & Related Records
연도 인용수 순위
  • Reference
1 de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008;111:1-66.
2 Sinkiewicz G, Ljunggren L. Occurrence of Lactobacillus reuteri in human breast milk. Microb Ecol Health Dis 2008;20:112-6.
3 Thomas DW, Greer FR; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics 2010;126:1217-31.   DOI
4 Pietzak M. Bacterial colonization of the neonatal gut. J Pediatr Gastroenterol Nutr 2004;38:389-91.   DOI
5 Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol 2001;2:43-53.
6 Huda S, Chaudhery S, Ibrahim H, Pramanik A. Neonatal necrotizing enterocolitis: clinical challenges, pathophysiology and management. Pathophysiology 2014;21:3-12.   DOI
7 Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008;122:693-700.   DOI
8 Wu SF, Caplan M, Lin HC. Necrotizing enterocolitis: old problem with new hope. Pediatr Neonatol 2012;53:158-63.   DOI
9 Chu A, Hageman JR, Caplan MS. Necrotizing enterocolitis predictive markers and preventive strategies. Neoreviews 2013;14:e113-20.   DOI
10 Shadkam MN, Jalalizadeh F, Nasiriani K. Effects of probiotic Lactobacillus reuteri (DSM 17938) on the incidence of necrotizing enterocolitis in very low birth weight premature infants. Iran J Neonatol 2015;6:15-20.
11 Athalye-Jape G, Rao S, Patole S. Lactobacillus reuteri DSM 17938 as a probiotic for preterm neonates: a strain-specific systematic review. JPEN J Parenter Enteral Nutr 2016;40:783-94.   DOI
12 Hunter C, Dimaguila MA, Gal P, Wimmer JE Jr, Ransom JL, Carlos RQ, et al. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight <1000 grams: a sequential analysis. BMC Pediatr 2012;12:142.   DOI
13 Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012;130:e1113-20.   DOI
14 Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr 2008;152:801-6.   DOI
15 Rao SC, Athalye-Jape GK, Deshpande GC, Simmer KN, Patole SK. Probiotic supplementation and lateonset sepsis in preterm infants: a meta-analysis. Pediatrics 2016;137:e20153684.   DOI
16 Oncel MY, Sari FN, Arayici S, Guzoglu N, Erdeve O, Uras N, et al. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2014;99:F110-5.   DOI
17 AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014;(4):CD005496.
18 Lee JH. An update on necrotizing enterocolitis: pathogenesis and preventive strategies. Korean J Pediatr 2011;54:368-72.   DOI
19 Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis 2015;60 Suppl 2:S129-34.   DOI
20 Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol 2013;47:437-9.   DOI
21 Wejryd E, Marchini G, Frimmel V, Jonsson B, Abrahamsson T. Probiotics promoted head growth in extremely low birthweight infants in a double-blind placebo-controlled trial. Acta Paediatr 2019;108:62-9.   DOI
22 Kaban RK. Analisis dampak perbedaan pajanan konsentrasi oksigen awal pada resusitasi bayi prematur terhadap displasia bronkopulmonal, integritas mukosa, dan mikrobiota usus, disertasi. Jakarta: Universitas Indonesia, 2016.
23 Sjarif DR, Rohsiswatmo R, Rundjan L, Yuliarti K. Panduan berbasis bukti: asuhan nutrisi untuk bayi prematur. Jakarta: Departemen Ilmu Kesehatan Anak FKUI-RSCM, 2016.
24 Khashana A, Moussa R. Incidence of feeding intolerance in preterm neonates in neonatal intensive care units, Port Said, Egypt. J Clin Neonatol 2016;5:230-2.   DOI
25 Dominguez KM, Moss RL. Necrotizing enterocolitis. Clin Perinatol 2012;39:387-401.   DOI
26 Christensen RD, Lambert DK, Baer VL, Gordon PV. Necrotizing enterocolitis in term infants. Clin Perinatol 2013;40:69-78.   DOI
27 Schanler RJ. Human milk is the feeding strategy to prevent necrotizing enterocolitis. Curr Pediatr Rep 2014;2:264-8.   DOI
28 van den Akker CHP, van Goudoever JB, Szajewska H, Embleton ND, Hojsak I, Reid D; ESPGHAN Working Group for Probiotics, Prebiotics & Committee on Nutrition Probiotics for preterm infants: a strainspecific systematic review and network meta-analysis. J Pediatr Gastroenterol Nutr 2018;67:103-22.   DOI
29 Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 2012;47:241-8.   DOI
30 Escribano E, Zozaya C, Madero R, Sanchez L, van Goudoever J, Rodriguez JM, et al. Increased incidence of necrotizing enterocolitis associated with routine administration of $Infloran^{TM}$ in extremely preterm infants. Benef Microbes 2018;9:683-90.   DOI
31 Pabst O, Cerovic V, Hornef M. Secretory IgA in the coordination of establishment and maintenance of the microbiota. Trends Immunol 2016;37:287-96.   DOI
32 Romeo MG, Romeo DM, Trovato L, Oliveri S, Palermo F, Cota F, et al. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol 2011;31:63-9.   DOI
33 Ofek Shlomai N, Deshpande G, Rao S, Patole S. Probiotics for preterm neonates: what will it take to change clinical practice? Neonatology 2014;105:64-70.   DOI
34 Indrio F, Riezzo G, Tafuri S, Ficarella M, Carlucci B, Bisceglia M, et al. Probiotic supplementation in preterm: feeding intolerance and hospital cost. Nutrients 2017;9:E965.   DOI